89 results
8-K
EX-10.1
INBS
Intelligent Bio Solutions Inc
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
accountability, (c) access to assets is permitted only in accordance with management’s general or specific authorization, and (d) the recorded accountability … from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect
8-K
EX-10.2
INBS
Intelligent Bio Solutions Inc
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
29 Feb 24
Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway
5:00pm
first step in this process. Our focus is on ensuring we remain on track for our planned entry into the US market and expand access to our innovative
8-K
EX-1.1
nky6z0y mury
4 Oct 23
Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering
5:27pm
424B4
6nm6isa8k29548cpf08
3 Oct 23
Prospectus supplement with pricing info
4:52pm
8-K
EX-99.1
x1pdcmysb waaipg
25 Aug 23
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Operational Highlights
8:00am